يعرض 1 - 20 نتائج من 120 نتيجة بحث عن '"Louie Naumovski"', وقت الاستعلام: 0.60s تنقيح النتائج
  1. 1
    Efficacy and safety of dilpacimab (ABT-165) versus bevacizumab plus FOLFIRI in metastatic colorectal cancer: a phase II study

    المؤلفون: John H Strickler, Antonio Cubillo, Jin-Tung Liang, Marc Matrana, Mark Kozloff, Thomas Lowe, Martha Blaney, Mohammad Sahtout, Louie Naumovski, Zev A Wainberg

    المصدر: Future Oncology. 18:3011-3020

    مصطلحات موضوعية: Cancer Research, Rectal Neoplasms, Leucovorin, Antineoplastic Agents, General Medicine, Disease-Free Survival, Bevacizumab, Oncology, Antineoplastic Combined Chemotherapy Protocols, Colonic Neoplasms, Humans, Camptothecin, Fluorouracil, Colorectal Neoplasms

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f1c01fa7f5da30351406a1f56ba4f79
    https://doi.org/10.2217/fon-2021-1603

    View record in OpenAIRE

    أضف إلى المفضلة
  2. 2
    Figure S1 from Phase I Dose-Escalation and -Expansion Study of Telisotuzumab (ABT-700), an Anti–c-Met Antibody, in Patients with Advanced Solid Tumors

    المؤلفون: Ramesh K. Ramanathan, Louie Naumovski, Daniel Afar, Edward Reilly, Lan Wang, Huibin Yue, Shekman Wong, Monica Motwani, Peter Ansell, Chia-Chi Lin, Chia Jui Yen, Yoon-Koo Kang, Ravi Salgia, Patricia LoRusso, John H. Strickler

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::145067315457d206ba429757f27f4a59
    https://doi.org/10.1158/1535-7163.22518675.v1

    View record in OpenAIRE

    أضف إلى المفضلة
  3. 3
    Data from Phase I Dose-Escalation and -Expansion Study of Telisotuzumab (ABT-700), an Anti–c-Met Antibody, in Patients with Advanced Solid Tumors

    المؤلفون: Ramesh K. Ramanathan, Louie Naumovski, Daniel Afar, Edward Reilly, Lan Wang, Huibin Yue, Shekman Wong, Monica Motwani, Peter Ansell, Chia-Chi Lin, Chia Jui Yen, Yoon-Koo Kang, Ravi Salgia, Patricia LoRusso, John H. Strickler

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6640b77d2b8eba127728d9cdd567b7c4
    https://doi.org/10.1158/1535-7163.c.6542055.v1

    View record in OpenAIRE

    أضف إلى المفضلة
  4. 4
    Table S2 from Phase I Dose-Escalation and -Expansion Study of Telisotuzumab (ABT-700), an Anti–c-Met Antibody, in Patients with Advanced Solid Tumors

    المؤلفون: Ramesh K. Ramanathan, Louie Naumovski, Daniel Afar, Edward Reilly, Lan Wang, Huibin Yue, Shekman Wong, Monica Motwani, Peter Ansell, Chia-Chi Lin, Chia Jui Yen, Yoon-Koo Kang, Ravi Salgia, Patricia LoRusso, John H. Strickler

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::724d29e98782b3d44b4991678c167d4f
    https://doi.org/10.1158/1535-7163.22518666

    View record in OpenAIRE

    أضف إلى المفضلة
  5. 5
    Supplementary Tables S1-S5 and Figures S1-S4 from ABT-165, a Dual Variable Domain Immunoglobulin (DVD-Ig) Targeting DLL4 and VEGF, Demonstrates Superior Efficacy and Favorable Safety Profiles in Preclinical Models

    المؤلفون: Susan E. Morgan-Lappe, Jijie Gu, Louie Naumovski, Sherry L. Ralston, Wenqing Gao, Surekha S. Akella, Catherine Zhang, Sarah R. Mudd, Fang Jiang, Sanjay C. Panchal, Enrico L. DiGiammarino, Lucia J. Eaton, Kelly D. Foster-Duke, Deanna L. Haasch, Dominic J. Ambrosi, Jonathan A. Hickson, Yingchun Li

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::948fdfba3f05b8a422e19034176fe36d
    https://doi.org/10.1158/1535-7163.22505686

    View record in OpenAIRE

    أضف إلى المفضلة
  6. 6
    Supplementary Materials and Methods from ABT-165, a Dual Variable Domain Immunoglobulin (DVD-Ig) Targeting DLL4 and VEGF, Demonstrates Superior Efficacy and Favorable Safety Profiles in Preclinical Models

    المؤلفون: Susan E. Morgan-Lappe, Jijie Gu, Louie Naumovski, Sherry L. Ralston, Wenqing Gao, Surekha S. Akella, Catherine Zhang, Sarah R. Mudd, Fang Jiang, Sanjay C. Panchal, Enrico L. DiGiammarino, Lucia J. Eaton, Kelly D. Foster-Duke, Deanna L. Haasch, Dominic J. Ambrosi, Jonathan A. Hickson, Yingchun Li

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::267ca9367d459176dea46bdd55158c64
    https://doi.org/10.1158/1535-7163.22505689.v1

    View record in OpenAIRE

    أضف إلى المفضلة
  7. 7
    Data from ABT-165, a Dual Variable Domain Immunoglobulin (DVD-Ig) Targeting DLL4 and VEGF, Demonstrates Superior Efficacy and Favorable Safety Profiles in Preclinical Models

    المؤلفون: Susan E. Morgan-Lappe, Jijie Gu, Louie Naumovski, Sherry L. Ralston, Wenqing Gao, Surekha S. Akella, Catherine Zhang, Sarah R. Mudd, Fang Jiang, Sanjay C. Panchal, Enrico L. DiGiammarino, Lucia J. Eaton, Kelly D. Foster-Duke, Deanna L. Haasch, Dominic J. Ambrosi, Jonathan A. Hickson, Yingchun Li

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::2454e519448df5024c51607be68974ce
    https://doi.org/10.1158/1535-7163.c.6538150.v1

    View record in OpenAIRE

    أضف إلى المفضلة
  8. 8
    Supplementary Table S1 from First-in-Human Phase I Study of ABBV-085, an Antibody–Drug Conjugate Targeting LRRC15, in Sarcomas and Other Advanced Solid Tumors

    المؤلفون: Victor M. Villalobos, Anthony Tolcher, James P. Allison, Padmanee Sharma, Randy Robinson, James W. Purcell, Akshanth R. Polepally, Huibin Yue, Dominic W. Lai, Hua Fang, Chris Chen, Louie Naumovski, Vivek Subbiah, Alexander I. Spira, John D. Powderly, Antoine Hollebecque, Jason J. Luke, George D. Demetri

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::271adc4d902f52091fabcde75c704e43
    https://doi.org/10.1158/1078-0432.22479059.v1

    View record in OpenAIRE

    أضف إلى المفضلة
  9. 9
    Data from ABBV-399, a c-Met Antibody–Drug Conjugate that Targets Both MET–Amplified and c-Met–Overexpressing Tumors, Irrespective of MET Pathway Dependence

    المؤلفون: Edward B. Reilly, Louie Naumovski, Joann P. Palma, Edward K. Han, Qian Zhang, Lora Tucker, Erwin R. Boghaert, Kedar S. Vaidya, Anatol Oleksijew, Mark G. Anderson, Jieyi Wang

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7da2bd78ea69eb0cc09b70d81041cc0c
    https://doi.org/10.1158/1078-0432.c.6526458

    View record in OpenAIRE

    أضف إلى المفضلة
  10. 10
    Supplementary Figures 1-2 from ABBV-399, a c-Met Antibody–Drug Conjugate that Targets Both MET–Amplified and c-Met–Overexpressing Tumors, Irrespective of MET Pathway Dependence

    المؤلفون: Edward B. Reilly, Louie Naumovski, Joann P. Palma, Edward K. Han, Qian Zhang, Lora Tucker, Erwin R. Boghaert, Kedar S. Vaidya, Anatol Oleksijew, Mark G. Anderson, Jieyi Wang

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97d3a01cbd3c45e92267639c0dd014a8
    https://doi.org/10.1158/1078-0432.22466868

    View record in OpenAIRE

    أضف إلى المفضلة
  11. 11
    Data from The Novel Expanded Porphyrin, Motexafin Gadolinium, Combined with [90Y]Ibritumomab Tiuxetan for Relapsed/Refractory Non-Hodgkin's Lymphoma: Preclinical Findings and Results of a Phase I Trial

    المؤلفون: Leo I. Gordon, Richard A. Miller, Jane N. Winter, Steven T. Rosen, Louie Naumovski, Jun Chen, Daina Variakojis, Elizabeth Hamilton, Sarah Miyata, Borko D. Jovanovic, Stewart Spies, David Patton, Irene B. Helenowski, William G. Spies, Andrew M. Evens

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f54f59e963f38826f3289d0bd4b4225
    https://doi.org/10.1158/1078-0432.c.6516849

    View record in OpenAIRE

    أضف إلى المفضلة
  12. 12
    Supplementary Figure S1 from First-in-Human Phase I Study of ABBV-085, an Antibody–Drug Conjugate Targeting LRRC15, in Sarcomas and Other Advanced Solid Tumors

    المؤلفون: Victor M. Villalobos, Anthony Tolcher, James P. Allison, Padmanee Sharma, Randy Robinson, James W. Purcell, Akshanth R. Polepally, Huibin Yue, Dominic W. Lai, Hua Fang, Chris Chen, Louie Naumovski, Vivek Subbiah, Alexander I. Spira, John D. Powderly, Antoine Hollebecque, Jason J. Luke, George D. Demetri

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9f740555983e19b1c823b9f0c6228f7
    https://doi.org/10.1158/1078-0432.22479068.v1

    View record in OpenAIRE

    أضف إلى المفضلة
  13. 13
    Supplementary Data from The Novel Expanded Porphyrin, Motexafin Gadolinium, Combined with [90Y]Ibritumomab Tiuxetan for Relapsed/Refractory Non-Hodgkin's Lymphoma: Preclinical Findings and Results of a Phase I Trial

    المؤلفون: Leo I. Gordon, Richard A. Miller, Jane N. Winter, Steven T. Rosen, Louie Naumovski, Jun Chen, Daina Variakojis, Elizabeth Hamilton, Sarah Miyata, Borko D. Jovanovic, Stewart Spies, David Patton, Irene B. Helenowski, William G. Spies, Andrew M. Evens

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::870b20ebfd695d1950590e81ace0f8df
    https://doi.org/10.1158/1078-0432.22439376

    View record in OpenAIRE

    أضف إلى المفضلة
  14. 14
    Phase I Open-Label Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Dilpacimab in Patients with Advanced Solid Tumors

    المؤلفون: Susan E. Morgan-Lappe, Zev A. Wainberg, Ramesh K. Ramanathan, Huibin Yue, Martha Elizabeth Blaney, Louie Naumovski, John H. Strickler, Lan Wang, John Nemunaitis, George W. Sledge, Erika Hamilton, Sreeneeranj Kasichayanula, Minal A. Barve, Michael S. Gordon, Monica Motwani

    المصدر: Molecular cancer therapeutics, vol 20, iss 10

    مصطلحات موضوعية: Vascular Endothelial Growth Factor A, Adult, Male, Cancer Research, medicine.medical_specialty, Maximum Tolerated Dose, Clinical Trials and Supportive Activities, Oncology and Carcinogenesis, Antineoplastic Agents, Gastroenterology, Antibodies, Prostate cancer, Rare Diseases, Pharmacokinetics, Clinical Research, Gastrointestinal perforation, Neoplasms, Internal medicine, Antibodies, Bispecific, medicine, Humans, Tissue Distribution, Oncology & Carcinogenesis, Adverse effect, Adaptor Proteins, Signal Transducing, Aged, Cancer, business.industry, Calcium-Binding Proteins, Signal Transducing, Adaptor Proteins, Evaluation of treatments and therapeutic interventions, Pharmacology and Pharmaceutical Sciences, Middle Aged, Prognosis, medicine.disease, Ovarian Cancer, Orphan Drug, Oncology, Tolerability, 6.1 Pharmaceuticals, Pharmacodynamics, Bispecific, Female, Patient Safety, Ovarian cancer, business, Progressive disease, Follow-Up Studies

    وصف الملف: application/pdf

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53aadea40691048a1e4ced92e1801356
    https://doi.org/10.1158/1535-7163.mct-20-0985

    View record in OpenAIRE

    أضف إلى المفضلة
  15. 15
    A first-in-human, phase 1, dose-escalation study of ABBV-176, an antibody-drug conjugate targeting the prolactin receptor, in patients with advanced solid tumors

    المؤلفون: Peter Ansell, Nancy Chan, Bo Tong, Louie Naumovski, Jasgit C. Sachdev, Charlotte Lemech, Christine K. Ratajczak, Joanne E. Mortimer, Silpa Nuthalapati, Fang Jiang, Natasha Woodward

    المصدر: Investigational New Drugs. 38:1815-1825

    مصطلحات موضوعية: Adult, Male, 0301 basic medicine, medicine.medical_specialty, Immunoconjugates, Receptors, Prolactin, Colorectal cancer, Nausea, Antineoplastic Agents, Neutropenia, Gastroenterology, 03 medical and health sciences, 0302 clinical medicine, Breast cancer, Pharmacokinetics, Neoplasms, Internal medicine, Humans, Medicine, Pharmacology (medical), Adverse effect, Aged, Pharmacology, business.industry, Prolactin receptor, Middle Aged, medicine.disease, Treatment Outcome, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Toxicity, Female, medicine.symptom, business

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f8739709fc76bd83923a956d67d0f01
    https://doi.org/10.1007/s10637-020-00960-z

    View record in OpenAIRE

    أضف إلى المفضلة
  16. 16
    First-in-Human Phase I Study of ABBV-085, an Antibody-Drug Conjugate Targeting LRRC15, in Sarcomas and Other Advanced Solid Tumors

    المؤلفون: Vivek Subbiah, Louie Naumovski, Hua Fang, Antoine Hollebecque, George D. Demetri, Chris Chen, Victor M. Villalobos, Jason J. Luke, Alexander I. Spira, Padmanee Sharma, Dominic W. Lai, James P. Allison, James W. Purcell, Anthony W. Tolcher, Randy Robinson, Akshanth R. Polepally, Huibin Yue, John D. Powderly

    المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research. 27(13)

    مصطلحات موضوعية: 0301 basic medicine, Oncology, Adult, Cancer Research, medicine.medical_specialty, Antibody-drug conjugate, Immunoconjugates, Combination therapy, Nausea, Antineoplastic Agents, Bone Neoplasms, 03 medical and health sciences, 0302 clinical medicine, Pharmacokinetics, Internal medicine, Neoplasms, medicine, Tumor Microenvironment, Humans, Adverse effect, business.industry, Membrane Proteins, Sarcoma, medicine.disease, Gemcitabine, 030104 developmental biology, 030220 oncology & carcinogenesis, Pharmacodynamics, Osteosarcoma, medicine.symptom, business, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7b06683d20ddbed17cd79560bf6e4f0
    https://pubmed.ncbi.nlm.nih.gov/33820780

    View record in OpenAIRE

    أضف إلى المفضلة
  17. 17
    First-in-Human Phase I, Dose-Escalation and -Expansion Study of Telisotuzumab Vedotin, an Antibody–Drug Conjugate Targeting c-Met, in Patients With Advanced Solid Tumors

    المؤلفون: Apurvasena Parikh, Colin D. Weekes, Monica Motwani, Daniel Morgensztern, Huibin Yue, Edward B. Reilly, John Nemunaitis, Todd M. Bauer, Ramesh K. Ramanathan, Daniel E. H. Afar, Rebecca S. Heist, Karen Kelly, Eric Angevin, John H. Strickler, Louie Naumovski

    المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol 36, iss 33
    Strickler, JH; Weekes, CD; Nemunaitis, J; Ramanathan, RK; Heist, RS; Morgensztern, D; et al.(2018). First-in-Human Phase I, Dose-Escalation and-Expansion Study of Telisotuzumab Vedotin, an Antibody-Drug Conjugate Targeting c-Met, in Patients With Advanced Solid Tumors.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, JCO2018787697. doi: 10.1200/jco.2018.78.7697. UC Davis: Retrieved from: http://www.escholarship.org/uc/item/8bt41691

    مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Oncology, Cancer Research, Antibody-drug conjugate, medicine.medical_specialty, C-Met, Maximum Tolerated Dose, Oncology and Carcinogenesis, Clinical Sciences, Antineoplastic Agents, and over, Antibodies, Dose-Response Relationship, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Pharmacokinetics, Neoplasms, Internal medicine, Monoclonal, 80 and over, medicine, Humans, Oncology & Carcinogenesis, Lung cancer, Aged, biology, business.industry, Middle Aged, Proto-Oncogene Proteins c-met, medicine.disease, Clinical trial, 030104 developmental biology, Tolerability, chemistry, 030220 oncology & carcinogenesis, biology.protein, Immunohistochemistry, Female, Drug, Antibody, business

    وصف الملف: application/pdf

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59f5a39884570dceb24fe57895eaac1b
    https://doi.org/10.1200/jco.2018.78.7697

    View record in OpenAIRE

    أضف إلى المفضلة
  18. 18
    ABT-165, a Dual Variable Domain Immunoglobulin (DVD-Ig) Targeting DLL4 and VEGF, Demonstrates Superior Efficacy and Favorable Safety Profiles in Preclinical Models

    المؤلفون: Susan E. Morgan-Lappe, Wenqing Gao, Enrico L. Digiammarino, Yingchun Li, Surekha S. Akella, Sanjay C. Panchal, Jonathan Hickson, Sarah R. Mudd, Louie Naumovski, Jijie Gu, Ralston Sherry L, Dominic J. Ambrosi, Catherine Zhang, Kelly Foster-Duke, Lucia Eaton, Fang Jiang, Deanna L. Haasch

    المصدر: Molecular Cancer Therapeutics. 17:1039-1050

    مصطلحات موضوعية: Vascular Endothelial Growth Factor A, 0301 basic medicine, Cancer Research, Angiogenesis, medicine.medical_treatment, Cell, Immunoglobulins, 03 medical and health sciences, 0302 clinical medicine, Pharmacokinetics, In vivo, Cell Line, Tumor, Antineoplastic Combined Chemotherapy Protocols, medicine, Animals, Humans, Immunologic Factors, Chemotherapy, biology, business.industry, Intracellular Signaling Peptides and Proteins, Membrane Proteins, Cancer, medicine.disease, Xenograft Model Antitumor Assays, Macaca fascicularis, Treatment Outcome, 030104 developmental biology, medicine.anatomical_structure, Oncology, 030220 oncology & carcinogenesis, Toxicity, biology.protein, Cancer research, Drug Screening Assays, Antitumor, Antibody, Glioblastoma, business, HT29 Cells

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c6f9d4850f963b7e646c9f59b8c47c7
    https://doi.org/10.1158/1535-7163.mct-17-0800

    View record in OpenAIRE

    أضف إلى المفضلة
  19. 19
    Academic Journal
    Molecular Cancer BioMed Central

    المؤلفون: Zhong Wang, Philip S Lecane, Patricia Thiemann, Qing Fan, Cecilia Cortez, Xuan Ma, Danielle Tonev, Dale Miles, Louie Naumovski, Richard A Miller, Darren Magda, Dong-gyu Cho, Jonathan L Sessler, Brian L Pike, Samantha M Yeligar, Mazen W Karaman, Joseph G Hacia

    المساهمون: The Pennsylvania State University CiteSeerX Archives

    المصدر: ftp://ftp.ncbi.nlm.nih.gov/pub/pmc/ed/45/Mol_Cancer_2007_Jan_19_6_9.tar.gz

    وصف الملف: application/zip

    Relation: http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.280.754

    الاتاحة: http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.280.754

    View record in BASE

    أضف إلى المفضلة
  20. 20
    Phase I Dose-Escalation and -Expansion Study of Telisotuzumab (ABT-700), an Anti-c-Met Antibody, in Patients with Advanced Solid Tumors

    المؤلفون: Ramesh K. Ramanathan, Chia-Chi Lin, John H. Strickler, Chia Jui Yen, Yoon-Koo Kang, Louie Naumovski, Huibin Yue, Edward B. Reilly, Ravi Salgia, Lan Wang, Peter Ansell, Daniel E. H. Afar, Patricia LoRusso, Shekman Wong, Monica Motwani

    المصدر: Molecular cancer therapeutics. 19(5)

    مصطلحات موضوعية: 0301 basic medicine, Adult, Male, Cancer Research, medicine.medical_specialty, C-Met, Maximum Tolerated Dose, Gastroenterology, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Stable Disease, Pharmacokinetics, Internal medicine, Neoplasms, medicine, Humans, Tissue Distribution, Hypoalbuminemia, Prospective Studies, Adverse effect, Aged, Retrospective Studies, Aged, 80 and over, biology, business.industry, Antibodies, Monoclonal, Middle Aged, Proto-Oncogene Proteins c-met, medicine.disease, Prognosis, 030104 developmental biology, Oncology, chemistry, Response Evaluation Criteria in Solid Tumors, 030220 oncology & carcinogenesis, biology.protein, Female, Antibody, business, Progressive disease, Follow-Up Studies

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eeba7f7611f9588ebc09e0c63651e65a
    https://pubmed.ncbi.nlm.nih.gov/32127466

    View record in OpenAIRE

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء